Efficacy and tolerability of aripiprazole in adolescents with schizophrenia

被引：0
|
作者：
Forbes, A. [1 ]
Nyilas, M. [1 ]
Loze, J. [2 ]
Werner, C. [3 ]
Johnson, B. [1 ]
Owen, R. [4 ]
Todorov, S. [5 ]
Carson, W. H. [1 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
[2] Otsuka Pharmaceut France SAS, Rueil Malmaison, France
[3] Otsuka Frankfurt Res Inst, Frankfurt, Germany
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[5] Multiprofiled Hosp Act Treatment, Psychiat Clin 1, Varna, Bulgaria
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.786
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [41] The efficacy and tolerability of memantine in the therapy of schizophrenia
    Ionescu, Daniela
    Dehelean, Cristina
    Dragan, Simona
    TOXICOLOGY LETTERS, 2009, 189 : S251 - S251
  • [42] Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia: An Open-Label Trial
    Takahashi, Hitoshi
    Oshimo, Takashi
    Ishigooka, Jun
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 149 - 150
  • [43] Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
    Pagsberg, Anne Katrine
    Jeppesen, Pia
    Klauber, Dea Gowers
    Jensen, Karsten Gjessing
    Ruda, Ditte
    Stentebjerg-Olesen, Marie
    Jantzen, Peter
    Rasmussen, Simone
    Saldeen, Eva Ann-Sofie
    Lauritsen, Maj-Britt Glenn
    Bilenberg, Niels
    Stenstrom, Anne Dorte
    Pedersen, Jesper
    Nyvang, Louise
    Madsen, Sarah
    Lauritsen, Marlene B.
    Vernal, Ditte Lammers
    Thomsen, Per Hove
    Paludan, Jakob
    Werge, Thomas M.
    Winge, Kristian
    Juul, Klaus
    Gluud, Christian
    Skoog, Maria
    Wetterslev, Jorn
    Jepsen, Jens Richardt M.
    Correll, Christoph U.
    Fink-Jensen, Anders
    Fagerlund, Birgitte
    BMC PSYCHIATRY, 2014, 14
  • [44] Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial
    Anne Katrine Pagsberg
    Pia Jeppesen
    Dea Gowers Klauber
    Karsten Gjessing Jensen
    Ditte Rudå
    Marie Stentebjerg-Olesen
    Peter Jantzen
    Simone Rasmussen
    Eva Ann-Sofie Saldeen
    Maj-Britt Glenn Lauritsen
    Niels Bilenberg
    Anne Dorte Stenstrøm
    Jesper Pedersen
    Louise Nyvang
    Sarah Madsen
    Marlene B Lauritsen
    Ditte Lammers Vernal
    Per Hove Thomsen
    Jakob Paludan
    Thomas M Werge
    Kristian Winge
    Klaus Juul
    Christian Gluud
    Maria Skoog
    Jørn Wetterslev
    Jens Richardt M Jepsen
    Christoph U Correll
    Anders Fink-Jensen
    Birgitte Fagerlund
    BMC Psychiatry, 14
  • [45] Efficacy of aripiprazole-IM-depot in the treatment of schizophrenia
    Kane, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S444 - S444
  • [46] Olanzapine efficacy and tolerability in adolescents with schizophrenia: results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher
    Frazier, Jean
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 879 - 879
  • [47] Olanzapine efficacy and tolerability in adolescents with schizophrenia: Results from an open-label extension phase
    Robertson-Plouch, Carol
    Kryzhanovskaya, Ludmila
    Schulz, Charles
    McDougle, Christopher J.
    Frazier, Jean A.
    Xu, Wen
    Carlson, Janice
    Tohen, Mauricio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S216
  • [48] Meta-analysis of efficacy of aripiprazole in the treatment of schizophrenia
    Carson, WH
    Stock, E
    Saha, AR
    Ali, M
    McQuade, RD
    Kujawa, MJ
    Ingenito, G
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 186 - 186
  • [49] EFFECT OF ARIPIPRAZOLE COMBINED WITH OLANZAPINE ON THE CLINICAL EFFICACY OF SCHIZOPHRENIA
    Jia, Tiancheng
    Len, Xue
    Pi, Zhilian
    Hong, Zhe
    Feng, Jin
    Ma, Chunhe
    FARMACIA, 2022, 70 (03) : 550 - 556
  • [50] Efficacy of aripiprazole for the treatment of schizophrenia: What dose is required?
    Charpeaud, T.
    Samalin, L.
    Llorca, P. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2014, 40 (01): : 62 - 73
12345